Beike, a bio-technology company that was founded with capital from Beijing University, Hong Kong University of Science and Technology and Shenzhen City Hall and supported by funds from the China State National Fund, is ready to treat its first non-asian foreign patients. Their research and clinical work comes as a collaboration of Beijing University, Hong Kong University of Science and Technology, No. 3 Army Medical University, Zhongshan Medical University, Guiyang Medical College and Zhenghou University. Throughout all of their collaborating laboratories, they have around 60 P.h.D. level or candidate level researchers focusing on stem cell research.

Currently they are in their clinical trial phase for foreign patients after treating more than 350 Chinese patients which means their first foreign patients will only need to pay the hospital charges for treatment. They are currently looking for western brain damage patients, stroke patients, and cerebral palsy patients.  The hospital stay is about 20 to 30 days with three to four injections. Patients who are interested can send feedback here.

As of July 1st, 2005, they treated 362 patients with stem cell injections with the most being for ALS (89), Brain Trauma (32), Cerebral Infarction (36), Cerebral Hemorrhage (20), Cerebral Palsy (20) and diabetic foot (152). They treat patients at hospitals in Chongqing, Shenyang, Qingdao, Shen Zhen and Zheng Zhou and, concentrating on using chord blood stem cells for treatment.

The treatment involves injections into the spinal cord fluid and are relatively painless. Some transcripts from their treatments are available in the patient experiences part of this web site. There are some before and after videos of a brain damage and stroke patient as well.

The China Stem Cell Staff has met ALS, brain damage and stroke patients who have received the treatment and have witnessed some treatments, before during and after. The ALS treatments seem to be about the same in effectiveness as Dr. Huang's treatments with the patients regressing in three to eight months. The two brain damaged patients we have seen have made the most impressive improvements and along with the stroke patients do not seem to regress - or at least from what we are told and from what we seen in a six month time frame and from talking to the patientes.